CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Report for D008105: Liver Cirrhosis, Biliary NIH

(Synonyms: Liver Cirrhosis, Biliary)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug848 Endoscopic management according to standard of care Wiki 1.00
drug754 Dexmethylphenidate Wiki 1.00

Correlated MeSH Terms (5)


Name (Synonyms) Correlation
D007565 Jaundice, NIH 1.00
D002761 Cholangitis NIH 1.00
D018281 Cholangiocarcinoma NIH 1.00
D041781 Jaundice, Obstructive NIH 1.00
D010190 Pancreatic Neoplasms NIH 0.58

Correlated HPO Terms (5)


Name (Synonyms) Correlation
HP:0030153 Cholangiocarcinoma HPO 1.00
HP:0002613 Biliary cirrhosis HPO 1.00
HP:0000952 Jaundice HPO 1.00
HP:0030151 Cholangitis HPO 1.00
HP:0002894 Neoplasm of the pancreas HPO 0.58

There is one clinical trial.

Clinical Trials


1 The Status of Advanced Endoscopy in the Era of COVID-19: a Multicenter Study

In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.

NCT04385147 Cholangitis, Secondary Biliary Cholangiocarcinoma Obstructive Jaundice Pancreas Cancer COVID-19 SARS-CoV-2 Other: Endoscopic management according to standard of care
MeSH:Cholangiocarcinoma Pancreatic Neoplasms Cholangitis Liver Cirrhosis, Biliary Jaundice Jaundice, Obstructive
HPO:Biliary cirrhosis Cholangiocarcinoma Cholangitis Jaundice Neoplasm of the pancreas

Primary Outcomes

Description: Investigators will report the baseline demographic data (age, gender, nationality) of all patients.

Measure: Age, gender, nationality

Time: 3 months

Description: Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients.

Measure: Indication for procedure, status of SARS-CoV-2 infection

Time: 3 months

Description: Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients.

Measure: Complete blood count and liver functions tests

Time: 3 months

Description: Investigators will report the procedure related complications.

Measure: procedure related complications

Time: 3 months

Secondary Outcomes

Description: Investigators will report wether the precautions lead to increase timing of the procedure

Measure: Effect of COVID-19 precautions on procedure time

Time: 3 months

Description: Investigators will report wether the precautions affected staff number (increased or decreased)

Measure: Effect of COVID-19 precautions on staff number

Time: 3 months


HPO Nodes